Array-based resequencing for mutations causing familial hypercholesterolemia.

Abstract excerpt

BACKGROUND: Familial hypercholesterolemia (FH) is a heterogeneous autosomal dominant disease with a prevalence of 1 in 500. To date, over 1200 unique pathogenic mutations have been identified in at least 3 genes. The large allelic and genetic heterogeneity of FH requires high-throughput, rapid, and affordable mutation detection technology to efficiently integrate molecular screening into clinical practice. We...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apolipoproteins B
• Share to Automation
• Share to Hyperlipoproteinemia Type II